SCHEMBL23919408

SCHEMBL23919408

Cc1ccc2c(oc3ccccc32)c1N(c1ccc2ccc3c(N(c4cccc5c4oc4ccccc45)c4c(C)ccc5c4oc4ccccc45)ccc4ccc1c2c43)c1cccc2c1oc1ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
HPGD P15428 3/20 0.36
HSD17B10 Q99714 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
TSHR P16473 2/20 0.36
CYP3A4 P08684 1/20 0.36
PGR P06401 1/20 0.33
PIK3CD O00329 1/20 0.32
PIK3CB P42338 1/20 0.32
PRKDC P78527 1/20 0.32
ALOX5 P09917 3/20 0.32
KDM4E B2RXH2 2/20 0.32
GAA P10253 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CYP2C19 P33261 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23919312 0.95 HPGD (0.33) ALDH1A1HPGDHSD17B10TDP1L3MBTL1
SCHEMBL23131471 0.95 HPGD (0.33) ALDH1A1HPGDHSD17B10TDP1L3MBTL1
SCHEMBL12206527 0.94 HPGD (0.34) ALDH1A1HPGDHSD17B10TDP1L3MBTL1
SCHEMBL24728519 0.93 ALDH1A1 (0.37) ALDH1A1HPGDHSD17B10TDP1L3MBTL1
SCHEMBL22382119 0.93 PGR (0.33) ALDH1A1HPGDHSD17B10TDP1L3MBTL1
SCHEMBL23919409 0.92 ALDH1A1 (0.36) ALDH1A1HPGDHSD17B10TDP1L3MBTL1
SCHEMBL23919445 0.91 MEN1 (0.34) MEN1KMT2ACYP2C19
SCHEMBL21473900 0.90 CYP1A2 (0.34) ALDH1A1HPGDHSD17B10TDP1L3MBTL1
SCHEMBL23919307 0.89 HPGD (0.35) ALDH1A1HPGDHSD17B10TDP1L3MBTL1
SCHEMBL21686945 0.88 PGR (0.35) ALDH1A1HPGDHSD17B10TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE IDEMITSU KOSAN CO.,LTD. (JP) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE OLA1, TAS2R19, TMEM109 ALDH1A1 541/4885HPGD 4701/4885HSD17B10 3671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.